Skip to content

PlayGait: A Dynamic Exoskeleton

PlayGait: A Dynamic Exoskeleton to Improve Community Ambulation

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05318690
Enrollment
1
Registered
2022-04-08
Start date
2022-03-11
Completion date
2023-01-03
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

pediatric, orthosis, exoskeleton

Brief summary

PlayGait is an investigational dynamic energy storage and return (ESR) lower-limb exoskeleton for young children with cerebral palsy (CP), that stores energy while the child is in the stance phase of walking and returns that energy in terminal stance and early swing phase of walking. PlayGait assists with the passive dynamics of walking through an exotendon (comprised of a spring in series with a cable). The overall objective of this investigational device is to promote correct walking patterns that encourage proper bone alignment, muscle recruitment, and strengthening during walking practice in young children with CP. The study will evaluate children with CP's activity levels in the community with and without PlayGait. The study will consist of three lab visits and two, 7-day periods at home.

Interventions

DEVICEPlayGait

PlayGait is a dynamic energy storing and returning lower-limb exoskeleton.

OTHERBaseline

Baseline condition with no prescribed or intervention lower-limb devices.

Sponsors

National Institute on Disability, Independent Living, and Rehabilitation Research
CollaboratorFED
Orthocare Innovations, LLC
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 4 Years
Healthy volunteers
No

Inclusion criteria

* Age 3 - 4 years (at time of informed consent) * Hemiplegic cerebral palsy * If child uses an ankle-foot orthosis (AFO), parent/caregiver is willing to have the child stop wearing their prescribed AFO during data collections (lab sessions and two 7-day periods at home) * Ability to walk at least 10 meters without the use of assistive devices or AFOs * Ability to walk at least 1 minute without the use of assistive devices or AFOs * Stiff knee gait - less than normal knee flexion during swing phase * Hip flexion passive range of motion contracture less than 20 degrees * Gross Motor Function Classification System (GMFCS) Levels I-II * Modified Ashworth Scale (MAS) \<=2 for the gastrocnemius soleus, rectus femoris, and hamstrings * Family has resources to attend all study sessions (transportation, schedule) * Ability to speak and understand in English

Exclusion criteria

* Orthopedic surgery in the last year * Foster children or wards of the state * Use wheelchair or stroller mobility as their primary method of independent mobility * Severe visual impairment such that the visual impairment itself functionally limits mobility * Phenol or Botox injections to the legs in the last 3 months * Uncontrolled seizure disorder, defined as any seizure in the last 3 months that influenced mobility skills and function (seizures which did not affect mobility are acceptable) * Lower limb fracture in the last 3 months * Planned surgery or changes to movement disorder medication during the study period * Inability to understand directions sufficiently to complete the study assessments * Cognitive, behavioral, or any other issues that may not allow for effective study participation * Unwilling to complete the study protocol

Design outcomes

Primary

MeasureTime frameDescription
Cadence7 days with baseline condition; 7 days with PlayGait conditionLow, medium, and high activity rate
Shifts in cadence7 days with baseline condition; 7 days with PlayGait conditionShifts from low to medium cadence and shifts from medium to high cadence

Secondary

MeasureTime frameDescription
Pediatric Balance Scale1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGaitParticipant completes 14 activity items that measure pediatric balance
1 minute walk test1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGaitThe distance walked in one minute
Time of PlayGait usePlayGait condition: 7 days in the community with PlayGaitAmount of time each day that PlayGait is worn
Average steps per dayBaseline Condition: 7 days in the community without PlayGait (no lower-limb assistive devices); PlayGait condition: 7 days with PlayGaitStep count per day
10 meter walk test1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGaitThe time it takes to walk 10 meters

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026